United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-421_21d2a6c0-a9bc-4a72-aca2-86a7e840c914
- Product NDC
- 71610-421
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160218
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (71610-421-30) · 71610-421-30
- 60 CAPSULE in 1 BOTTLE, PLASTIC (71610-421-53) · 71610-421-53
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71610-421-60) · 71610-421-60
- 180 CAPSULE in 1 BOTTLE, PLASTIC (71610-421-80) · 71610-421-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →